# Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum

> **NCT06719622** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Medical University of Warsaw** · enrollment: 114 (estimated)

## Conditions studied

- Crohn Disease (CD)

## Interventions

- **DRUG:** budesonide
- **DRUG:** omeprazole (proton pump inhibitor)

## Key facts

- **NCT ID:** NCT06719622
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06719622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06719622, "Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06719622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*